← Back to Search

Nicotine Replacement Therapy

John Hopkins Tobacco Treatment Clinic for Quitting Smoking

Phase < 1
Waitlist Available
Led By Mandeep S. Jassal, MD, MPH
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months
Awards & highlights

Study Summary

This trial is testing a new way to help parents of hospitalized children quit smoking, by providing counseling and education on the risks of secondhand and third hand smoke exposure, as well as information on NRT products.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Self-reported attempts to quit smoking
Secondary outcome measures
Change in Frequency of usage of outpatient tobacco cessation services
Change in Usage of nicotine replacement therapy products

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cessation interventionExperimental Treatment5 Interventions
All participants will receive nicotine replacement therapy and a referral to both Maryland Quitline and Johns Hopkins Tobacco Treatment Clinic for continued cessation care. Nicotine replacement therapy: Nicoderm patches, gum, lozenges Low nicotine dependence: Lozenge (2 mg) or Gum (2 mg) or Patch (7 mg) Moderate nicotine dependence: Patch (14 mg) and Lozenge (2 mg) or Gum (2 mg) High nicotine dependence: Patch (21 mg) and Lozenge (4 mg) or Gum (4 mg) Regardless of the level of nicotine addiction and subsequent dose of nicotine replacement therapy (NRT), participants of this trials are described as "recipients of NRT products".
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nicotine gum
2015
Completed Phase 4
~2250
Nicotine patch
2015
Completed Phase 4
~7450
Nicotine lozenge
2019
Completed Phase 4
~1940

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,259 Previous Clinical Trials
14,820,653 Total Patients Enrolled
Mandeep S. Jassal, MD, MPHPrincipal InvestigatorJohns Hopkins University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has Nicotine patch been used in past medical trials?

"Currently, 71 clinical trials exist for Nicotine patch. Of those, 5 are in their third phase of development. While the most studies take place in Augusta, Georgia there are also 204 other sites that have enrolled patients."

Answered by AI

What is the overall participation rate for this research experiment?

"Affirmative. A summary of the trial on clinicaltrials.gov indicates that recruitment is underway, with 50 patients sought from one site since its initial post on October 1st 2019 and most recent update November 10th 2022."

Answered by AI

Is this research endeavor currently accepting new participants?

"This medical study is actively enrolling participants, as noted on clinicaltrials.gov. The trial was initially posted in October of 2019 and updated most recently in November 2022."

Answered by AI

Who else is applying?

What state do they live in?
Florida
What site did they apply to?
Johns Hopkins Hospital
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
Recent research and studies
clinicaltrials.govStudy
Inpatient Smoking Cessation Pilot Program
2019. "Inpatient Smoking Cessation Pilot Program". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05060965.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top